Literature DB >> 30167957

Cerebral oxygenation declines but does not impair peak oxygen uptake during incremental cycling in women using oral contraceptives.

Karlee M Quinn1,2,3, François Billaut4, Andrew C Bulmer5,6, Clare L Minahan7,5.   

Abstract

PURPOSE: To compare prefrontal cortex oxygenation in recreationally-active women using oral contraceptives (WomenOC; n = 8) to women with a natural menstrual cycle (WomenNC; n = 8) during incremental exercise to exhaustion.
METHODS: Participants performed incremental cycling to exhaustion to determine lactate threshold 1 (LT1) and 2 (LT2) and peak oxygen uptake (VO2peak). Prefrontal cortex oxygenation was monitored via near-infrared spectroscopy through concentration changes in oxy-haemoglobin (Δ[HbO2]), deoxy-haemoglobin (Δ[HHb]), total-haemoglobin (Δ[tHb]) and tissue saturation index (TSI).
RESULTS: 17β-oestradiol and progesterone were lower in WomenOC (35 ± 26; 318 ± 127 pmol·L-1, respectively) than WomenNC (261 ± 156; 858 ± 541 pmol·L-1, respectively). There were no differences in full blood examination results or serum nitric oxide (p > 0.05). However, WomenOC presented lower concentrations in ferric-reducing ability of plasma (- 8%; effect size; ES - 0.52 ± 0.61), bilirubin (- 32%; ES - 0.56 ± 0.62) and uric acid (- 17%; ES - 0.53 ± 0.61). Cardiopulmonary parameters were similar between groups during cycling, including VO2peak (p = 0.99). While there was a significant effect of time on all parameters measured by near-infrared spectroscopy during incremental cycling, there was no effect of OC at LT1, LT2 or exhaustion calculated as a change from baseline (TSI; p = 0.096, Δ[HbO2]; p = 0.143, Δ[HHb]; p = 0.085 and Δ[tHb]; p = 0.226). The change in TSI from LT1 to LT2 was significantly different between groups (WomenNC; mean difference + 2.06%, WomenOC; mean difference - 1.73%; p = 0.003).
CONCLUSION: Prefrontal tissue oxygenation declined at a lower relative exercise intensity in WomenOC as compared to WomenNC, however, this did not influence VO2peak. The results provide the first evidence for variance in the cerebral oxygenation response to exercise, which may be associated with female sex hormones.

Entities:  

Keywords:  Aerobic exercise; Contraceptives; Female; Near infrared spectroscopy; Oral; Prefrontal cortex

Mesh:

Substances:

Year:  2018        PMID: 30167957     DOI: 10.1007/s00421-018-3968-y

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  53 in total

Review 1.  Influence of sex steroid hormones on cerebrovascular function.

Authors:  Diana N Krause; Sue P Duckles; Dale A Pelligrino
Journal:  J Appl Physiol (1985)       Date:  2006-06-22

2.  Menstrual cycle: no effect on exercise cardiorespiratory variables or blood lactate concentration.

Authors:  Gerhard Smekal; Serge P von Duvillard; Peter Frigo; Tina Tegelhofer; Rochus Pokan; Peter Hofmann; Harald Tschan; Ramon Baron; Manfred Wonisch; Karin Renezeder; Norbert Bachl
Journal:  Med Sci Sports Exerc       Date:  2007-07       Impact factor: 5.411

3.  Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome.

Authors:  J Patrick Neary; Andy D W Roberts; Nina Leavins; Michael F Harrison; James C Croll; James R Sexsmith
Journal:  Clin Physiol Funct Imaging       Date:  2008-07-29       Impact factor: 2.273

4.  Making meaningful inferences about magnitudes.

Authors:  Alan M Batterham; William G Hopkins
Journal:  Int J Sports Physiol Perform       Date:  2006-03       Impact factor: 4.010

5.  Middle cerebral artery blood velocity during controlled ovarian hyperstimulation.

Authors:  F N Shamma; P Fayad; L Brass; P Sarrel
Journal:  Fertil Steril       Date:  1992-05       Impact factor: 7.329

6.  Estrogen improves endothelial function.

Authors:  S Arora; A Veves; A E Caballaro; P Smakowski; F W LoGerfo
Journal:  J Vasc Surg       Date:  1998-06       Impact factor: 4.268

7.  Effect of long-term oral contraceptive use on determinants of endurance performance.

Authors:  Sarah Joyce; Surendran Sabapathy; Andrew Bulmer; Clare Minahan
Journal:  J Strength Cond Res       Date:  2013-07       Impact factor: 3.775

Review 8.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

9.  Three-step method for menstrual and oral contraceptive cycle verification.

Authors:  Mia A Schaumberg; David G Jenkins; Xanne A K Janse de Jonge; Lynne M Emmerton; Tina L Skinner
Journal:  J Sci Med Sport       Date:  2016-08-26       Impact factor: 4.319

10.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

View more
  4 in total

1.  Blood oxidative stress biomarkers in women: influence of oral contraception, exercise, and N-acetylcysteine.

Authors:  Karlee M Quinn; Llion Roberts; Amanda J Cox; David N Borg; Evan N Pennell; Daniel R McKeating; Joshua J Fisher; Anthony V Perkins; Clare Minahan
Journal:  Eur J Appl Physiol       Date:  2022-06-08       Impact factor: 3.346

2.  New Directions in Exercise Prescription: Is There a Role for Brain-Derived Parameters Obtained by Functional Near-Infrared Spectroscopy?

Authors:  Fabian Herold; Thomas Gronwald; Felix Scholkmann; Hamoon Zohdi; Dominik Wyser; Notger G Müller; Dennis Hamacher
Journal:  Brain Sci       Date:  2020-06-03

3.  The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis.

Authors:  Kirsty J Elliott-Sale; Kelly L McNulty; Paul Ansdell; Stuart Goodall; Kirsty M Hicks; Kevin Thomas; Paul A Swinton; Eimear Dolan
Journal:  Sports Med       Date:  2020-10       Impact factor: 11.136

4.  Temporal changes in blood oxidative stress biomarkers across the menstrual cycle and with oral contraceptive use in active women.

Authors:  Karlee M Quinn; Amanda J Cox; Llion Roberts; Evan N Pennell; Daniel R McKeating; Joshua J Fisher; Anthony V Perkins; Clare Minahan
Journal:  Eur J Appl Physiol       Date:  2021-06-09       Impact factor: 3.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.